Lester Mertz, M.D., rheumatologist at Mayo Clinic in Arizona, discusses an FDA approved, longitudinal protocol of patients with granulomatosis and polyangiitis as well as microscopic polyangiitis who are treated with a relatively new treatment. The study will help determine more accurately the benefit and side effect profile of this treatment.
Dr. Mertz and his colleagues at Mayo Clinic in Rochester and Mayo Clinic in Jacksonville are currently enrolling patients in this study. For more information, please visit http://clinicaltrials.mayo.edu/trial-details.cfm?trial_id=100929.